PLG and stroke disorder: The modulation of classical plasmin-dependent fibrinolysis offers therapeutic potential in the control of thrombosis and bleeding; recombinant tPA and TXA are widely used in clinical situations for embolic stroke and bleeding tendency, respectively16.